{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:46:24Z","timestamp":1780087584005,"version":"3.54.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11126-013-9253-7","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T11:51:33Z","timestamp":1361879493000},"page":"407-415","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacology and Pharmacogenetics of Pediatric ADHD with Associated Aggression: A Review"],"prefix":"10.1007","volume":"84","author":[{"given":"Bianca D.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew H.","family":"Barzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"9253_CR1","unstructured":"Bloom B, Cohen RA: Summary Health Statistics for U.S. Children: National Health Interview Survey, 2006. National Center for Health Statistics. DHHS Publication No. (PHS) 2007\u20131562, Hyattsville, 2007."},{"issue":"1","key":"9253_CR2","first-page":"27","volume":"15","author":"E Pappadopulos","year":"2006","unstructured":"Pappadopulos E, Woolston S, Chait A, Perkins M, Connor DF, Jensen PS: Pharmacotherapy of aggression in children and adolescents: Efficacy and effect size. Journal of the Canadian Academy of Child and Adolescent Psychiatry 15(1):27\u201339, 2006.","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"9253_CR3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.chi.0000157543.74509.c8","volume":"44","author":"NC Patel","year":"2005","unstructured":"Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP, et al.: Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child Adolescent Psychiatry 44(6):548\u2013556, 2005.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"3","key":"9253_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004583-200203000-00004","volume":"41","author":"DF Connor","year":"2002","unstructured":"Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RH: Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt\/covert aggression-related behaviors in ADHD. Journal of the American Academy of Child Adolescent Psychiatry 41(3):253\u2013261, 2002.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"5","key":"9253_CR5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/BF01670101","volume":"24","author":"GJ August","year":"1996","unstructured":"August GJ, Realmuto GM, MacDonald AW 3rd, Nugent SM, Crosby R: Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior. Journal of Abnormal Child Psychology 24(5):571\u2013595, 1996.","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"6","key":"9253_CR6","first-page":"51","volume":"34","author":"SF Butler","year":"1995","unstructured":"Butler SF, et. al.: Affective comorbidity in children and adolescents with attention deficit hyperactivity disorder. Journal of the American Academy of Child Adolescent Psychiatry 34(6):51\u201355, 1995.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"5","key":"9253_CR7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4088\/JCP.v67n0516","volume":"67","author":"DF Connor","year":"2006","unstructured":"Connor DF, Carlson GA, Chang KD, et al.: Juvenile maladaptive aggression: A review of prevention, treatment, and service configuration and a proposed research agenda. Journal of Clinical Psychiatry 67(5):808\u2013820, 2006.","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2 Suppl","key":"9253_CR8","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/00004583-200202001-00003","volume":"41","author":"LL Greenhill","year":"2002","unstructured":"Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al.: Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child Adolescent Psychiatry 41(2 Suppl): 26S\u201349S, 2002.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"2","key":"9253_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1469-7610.00110","volume":"44","author":"ML Wolraich","year":"2003","unstructured":"Wolraich ML: Annotation: The use of psychotropic medications in children: An American view. Journal of Child Psychology and Psychiatry 44(2): 159\u2013168, 2003.","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"Suppl 1","key":"9253_CR10","first-page":"102","volume":"13","author":"T Banaschewski","year":"2004","unstructured":"Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A: Non-stimulant medications in the treatment of ADHD. European Child and Adolescent Psychiatry 13(Suppl 1):102\u2013116, 2004.","journal-title":"European Child and Adolescent Psychiatry"},{"key":"9253_CR11","doi-asserted-by":"crossref","unstructured":"Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. American Journal of Psychiatry 166:992\u20131001, 2009. doi: 10.1176\/appi.ajp.2009.09040472 .","DOI":"10.1176\/appi.ajp.2009.09040472"},{"issue":"Suppl. 2","key":"9253_CR12","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/00004583-200202001-00003","volume":"41","author":"LL Greenhill","year":"2002","unstructured":"Greenhill LL, Pliszka S, Dulcan M Et al.: Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child Adolescent Psychiatry 41(Suppl. 2): S26\u2013S49, 2002.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR13","unstructured":"Crenshaw TM: Attention deficit hyperactivity disorder and the efficacy of stimulant medication: A meta-analysis [Dissertation]. Dissertation Abstracts International: Section B: The Sciences and Engineering, University of Virginia, pp. 1\u201377, 1997."},{"key":"9253_CR14","doi-asserted-by":"crossref","unstructured":"ML Wolraich, JN Hannah, A Baumgaertal, ID Feurer: Examination of DSM-IV criteria for attention-deficit\/hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics 19:162\u2013168, 1998.","DOI":"10.1097\/00004703-199806000-00003"},{"key":"9253_CR15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/00004583-199610000-00018","volume":"35","author":"CK Conners","year":"1996","unstructured":"Conners CK, Casat CD, Gualtieri CT, et al.: Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child Adolescent Psychiatry 35:1314\u20131321, 1996.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00004583-198909000-00022","volume":"28","author":"J Biederman","year":"1989","unstructured":"Biederman J, Baldessarini RJ, Wright V, et al.: A double-blind placebo controlled study of desipramine in the treatment of ADD, 1: Efficacy. Journal of the American Academy of Child Adolescent Psychiatry, 28:777\u2013784, 1989.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR17","doi-asserted-by":"crossref","unstructured":"Spencer T, Biederman J, Steingard R, et al.: Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. Journal of the American Academy of Child Adolescent Psychiatry, 32:211\u2013214, 1993.","DOI":"10.1097\/00004583-199301000-00030"},{"key":"9253_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/000992280003900102","volume":"39","author":"DF Connor","year":"2000","unstructured":"Connor DF, Barkley RA, Davis HT: A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics (Philadelphia) 39:15\u201325, 2000.","journal-title":"Clinical Pediatrics (Philadelphia)"},{"key":"9253_CR19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.CHI.0000046908.27264.00","volume":"42","author":"PL Hazell","year":"2003","unstructured":"Hazell PL, Stuart JE.: A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. Journal of the American Academy of Child Adolescent Psychiatry 42:886\u2013894, 2003.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00003495-198631040-00003","volume":"31","author":"EM Sorkin","year":"1986","unstructured":"Sorkin EM, Heel RC: Guanfacine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs 31: 301\u2013336, 1986.","journal-title":"Drugs"},{"key":"9253_CR21","first-page":"803","volume":"99","author":"J Kugler","year":"1990","unstructured":"Kugler J, Scus R, Krauskopf R, Brecht HM, Raschig A: Differences in psychic performance with guanfacine and clonidine in normotensive subjects. British Journal of Clinical Psychopharmacology l99: 803\u2013809, 1990.","journal-title":"British Journal of Clinical Psychopharmacology"},{"key":"9253_CR22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","volume":"34","author":"RD Hunt","year":"1995","unstructured":"Hunt RD, Arnsten AFD, Asbell MD: An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child Adolescent Psychiatry 34:50\u201354, 1995.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR23","unstructured":"Intuniv (guanfacine extended-release tablets): US prescribing information. Wayne, Shire Pharmaceuticals Inc., 2009."},{"issue":"11","key":"9253_CR24","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1523\/JNEUROSCI.08-11-04287.1988","volume":"8","author":"AFT Arnsten","year":"1988","unstructured":"Arnsten AFT, Cai JX, Goldman-Rakic PS: The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: Evidence for alpha-2 receptor subtypes. Journal of Neuroscience 8(11): 4287\u20134298, 1988.","journal-title":"Journal of Neuroscience"},{"key":"9253_CR25","unstructured":"Connor DF, Findling RL, Kollins SH, Sallee F, L\u00f3pez FA, Lyne A. et al.: Effects of guanfacine extended release on oppositional symptoms in children aged 6\u201312 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. Central Nervous System Drugs 24:755\u2013768, 2010."},{"key":"9253_CR26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.chi.0000163280.47221.c9","volume":"44","author":"M Weiss","year":"2005","unstructured":"Weiss M, Tannock R, Kratochvil C, Dunn D, Velez-Borras J, Thomason C, et al.: A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. Journal of the American Academy of Child Adolescent Psychiatry 44:647\u2013655, 2005.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1087054705281121","volume":"9","author":"SB Wigal","year":"2005","unstructured":"Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, et al.: A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school aged children with attention deficit\/hyperactivity disorder. Journal of Attention Disorder 9:275\u2013289, 2005.","journal-title":"Journal of Attention Disorder"},{"key":"9253_CR28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.chi.0000222788.34229.68","volume":"45","author":"CJ Kratochvil","year":"2006","unstructured":"Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, Feldman PD, et al.: Effects of long-term atomoxetine treatment for young children with attention-deficit\/hyperactivity disorder. Journal of the American Academy of Child Adolescent Psychiatry 45:919\u201327, 2006.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopsych.2006.05.044","volume":"61","author":"J Polzer","year":"2007","unstructured":"Polzer J, Bangs ME, Zhang S, Dellva MA, Tauscher-Wisniewski S, Acharya N, et al.: Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biological Psychiatry 61:713\u2013719, 2007.","journal-title":"Biological Psychiatry"},{"key":"9253_CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00002018-200326100-00006","volume":"26","author":"JF Wernicke","year":"2003","unstructured":"Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, Quintana H, Lipetz R, Michelson D, Heiligenstein J.: Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Safety 26:729\u2013740, 2003.","journal-title":"Drug Safety"},{"key":"9253_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004583-200302000-00007","volume":"42","author":"SB Schur","year":"2003","unstructured":"Schur SB, Sikich L, Findling RL, et al.: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY), pt 1: A review. Journal of the American Academy of Child Adolescent Psychiatry 42:132\u2013144, 2003.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","volume":"39","author":"RL Findling","year":"2000","unstructured":"Findling RL, McNamara NK, Branicky LA, et al.: A double-blind pilot study of risperidone in the treatment of conduct disorder. Journal of the American Academy of Child Adolescent Psychiatry 39:509\u2013516, 2000.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/104454601750143348","volume":"11","author":"M Bellinghen Van","year":"2001","unstructured":"Van Bellinghen M, De Troch C.: Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. Journal of Child Adolescent Psychopharmacology 11:5\u201313, 2001.","journal-title":"Journal of Child Adolescent Psychopharmacology"},{"key":"9253_CR34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","volume":"159","author":"MG Aman","year":"2002","unstructured":"Aman MG, De Smedt G, Derivan A, et al.: Double-blind, placebo- controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. American Journal of Psychiatry 159: 1337\u20131346, 2002.","journal-title":"American Journal of Psychiatry"},{"key":"9253_CR35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","volume":"41","author":"R Snyder","year":"2002","unstructured":"Snyder R, Turgay A, Aman MG, et al.: Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child Adolescent Psychiatry 41:1026\u20131036, 2002.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"5","key":"9253_CR36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/chi.0b013e3180323354","volume":"46","author":"JL Armenteros","year":"2007","unstructured":"Armenteros JL, Lewis JE, Davalos M: Risperidone augmentation for treatment-resistant aggression in attention-deficit\/hyperactivity disorder: A placebo-controlled pilot study. Journal of the American Academy of Child Adolescent Psychiatry 46(5):558\u2013565, 2007.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"1","key":"9253_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11126-010-9145-z","volume":"82","author":"BA List","year":"2011","unstructured":"List BA, Barzman DH: Evidence-based recommendations for the treatment of aggression in pediatric patients with attention deficit hyperactivity disorder. Psychiatr Quarterly 82(1):33\u201342, 2011.","journal-title":"Psychiatr Quarterly"},{"key":"9253_CR38","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4088\/JCP.v64n1113","volume":"64","author":"R Findling","year":"2003","unstructured":"Findling R, Kusumakar V, Daneman D, Moshang T, De Smedt G, Binder C: Prolactin levels during long-term risperidone treatment in children and adolescents. Journal of Clinical Psychiatry 64:1362\u20131369, 2003.","journal-title":"Journal of Clinical Psychiatry"},{"key":"9253_CR39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S1092852900018514","volume":"8","author":"H Steiner","year":"2003","unstructured":"Steiner H, Saxena K, Chang K.: Psychopharmacologic strategies for the treatment of aggression in juveniles. CNS Spectrums 8:298\u2013308, 2003.","journal-title":"CNS Spectrums"},{"issue":"4","key":"9253_CR40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004583-199504000-00011","volume":"34","author":"M Campbell","year":"1995","unstructured":"Campbell M, Adams PB, Small AM, Kafantaris V, Silva RR, Shell J, et al.: Lithium in hospitalized aggressive children with conduct disorder: A double-blind and placebo-controlled study. Journal of the American Academy of Child Adolescent Psychiatry 34(4):445\u2013453, 1995.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"2","key":"9253_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-7138(09)60909-2","volume":"21","author":"M Campbell","year":"1982","unstructured":"Campbell M, Cohen IL, Small AM: Drugs in aggressive behavior. Journal of the American Academy of Child Adolescent Psychiatry 21(2):107\u2013117, 1982.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"issue":"2","key":"9253_CR42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-7610.1992.tb00876.x","volume":"33","author":"GA Carlson","year":"1992","unstructured":"Carlson GA, Rapport MD, Pataki CS, Kelly KL: Lithium in hospitalized children at 4 and 8\u00a0weeks: Mood, behavior and cognitive effects. Journal of Child Psychology and Psychiatry 33(2):411\u2013425, 1992.","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"7","key":"9253_CR43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.57.7.649","volume":"57","author":"RP Malone","year":"2000","unstructured":"Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M: A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Archives of General Psychiatry 57(7):649\u2013654, 2000.","journal-title":"Archives of General Psychiatry"},{"key":"9253_CR44","first-page":"319","volume":"28","author":"RR Silva","year":"1992","unstructured":"Silva RR, Campbell M, Golden RR, Small AM, Pataki CS, Rosenberg CR: Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacology Bulletin 28:319\u2013326, 1992.","journal-title":"Psychopharmacology Bulletin"},{"key":"9253_CR45","volume-title":"Pharmacogenetics","author":"WW Weber","year":"1997","unstructured":"Weber WW: Pharmacogenetics. New York, Oxford Press, 1997."},{"key":"9253_CR46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1056-4993(18)30059-2","volume":"10","author":"SV Faraone","year":"2001","unstructured":"Faraone SV, Doyle AE: The nature and heritability of attention-deficit\/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 10:299\u2013316, 2001.","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"9253_CR47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00008571-199111000-00002","volume":"1","author":"UA Meyer","year":"1991","unstructured":"Meyer UA: Genotype or phenotype: The definition of a pharmacogenetic polymorphism. Pharmacogenetics 1:66\u201367, 1991.","journal-title":"Pharmacogenetics"},{"key":"9253_CR48","doi-asserted-by":"crossref","unstructured":"McGough JJ: Attention-deficit\/hyperactivity disorder pharmacogenomics. Biological Psychiatry 571367\u20131373, 2005.","DOI":"10.1016\/j.biopsych.2004.10.021"},{"key":"9253_CR49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1176\/appi.ajp.161.7.1173","volume":"161","author":"ND Volkow","year":"2004","unstructured":"Volkow ND, Wang G, Fowler JS, Telang F, Maynard L, Logan J: Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry 161: 1173\u2013118, 2004.","journal-title":"American Journal of Psychiatry"},{"key":"9253_CR50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","volume":"57","author":"T Spencer","year":"2005","unstructured":"Spencer T, et al: In vivo neuroreceptor imaging of ADHD. Biological Psychiatry 57:1293\u20131300, 2005.","journal-title":"Biological Psychiatry"},{"key":"9253_CR51","first-page":"319","volume":"35","author":"BG Winsberg","year":"1999","unstructured":"Winsberg BG, Comings DE: Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. Journal of the American Academy of Child Adolescent Psychiatry 35:319\u2013324, 1999.","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"9253_CR52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008571-200208000-00011","volume":"12","author":"T Roman","year":"2002","unstructured":"Roman T, Szobot C, Martine S, Biederman J, Rohde LA, Hutz MH: Dopamine transporter gene and response to methylphenidate in attention-deficit\/hyperactivity disorder. Pharmacogenetics 12:497\u2013499, 2002.","journal-title":"Pharmacogenetics"},{"key":"9253_CR53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.b.20071","volume":"121B","author":"A Kirley","year":"2003","unstructured":"Kirley A, Lowe N, Hawi A, Mullins C, Daly G, Waldman I, et al.: Association of the 480\u00a0bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. American Journal of Medical Genetics 121B:50\u201354, 2003.","journal-title":"American Journal of Medical Genetics"},{"key":"9253_CR54","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D Michelson","year":"2001","unstructured":"Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, et al.: Atomoxetine in the treatment of children and adolescent with attention-deficit\/hyperactivity disorder: A randomized placebo-controlled, dose-response study. Pediatrics 108:E83, 2001.","journal-title":"Pediatrics"},{"key":"9253_CR55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1146\/annurev.pharmtox.41.1.815","volume":"41","author":"H-G Xie","year":"2001","unstructured":"Xie H-G, Kim RB, Wood AJJ, Stein CM: Molecular basis of ethnic differences in drug disposition and response. Annual Review Pharmacology and Toxicology 41:815\u2013850, 2001.","journal-title":"Annual Review Pharmacology and Toxicology"},{"issue":"Suppl 12","key":"9253_CR56","first-page":"50","volume":"63","author":"JF Wernicke","year":"2002","unstructured":"Wernicke JF, Kratochvil CJ: Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. Journal of Clinical Psychiatry 63(suppl 12):50\u201355, 2002.","journal-title":"Journal of Clinical Psychiatry"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-013-9253-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11126-013-9253-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-013-9253-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T03:53:14Z","timestamp":1562730794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11126-013-9253-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9253"],"URL":"https:\/\/doi.org\/10.1007\/s11126-013-9253-7","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}